{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:15Z","timestamp":1784408835926,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,27]]},"DOI":"10.7759\/cureus.84929","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:54:37Z","timestamp":1748404477000},"source":"Crossref","is-referenced-by-count":1,"title":["Lamotrigine-Induced Toxic Epidermal Necrolysis (Lyell\u2019s Syndrome): A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Mourad","family":"Nafaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filda","family":"Messal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Miqdadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostapha","family":"Noussair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belyamani","family":"Lahcen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reval.2017.06.002","article-title":"N\u00e9crolyse \u00e9pidermique toxique: physiopathologie et avanc\u00e9es th\u00e9rapeutiques","volume":"57","author":"Villani A-P","year":"2017","unstructured":"Villani A-P, Vocanson M, Laoubi L. N\u00e9crolyse \u00e9pidermique toxique: physiopathologie et avanc\u00e9es th\u00e9rapeutiques. Rev Fr Allergol. 2017, 57:418-425. 10.1016\/j.reval.2017.06.002","journal-title":"Rev Fr Allergol"},{"key":"ref2","article-title":"Syndrome De Lyell Et Syndrome De Stevens-Johnson: \u00c9tude R\u00e9trospective De 30 Cas","volume":"35","author":"Hamich S","year":"2022","unstructured":"Hamich S, Sqalli Houssaini A, Meziane M, Ismaili N, Benzekri L, Senouci K. Syndrome De Lyell Et Syndrome De Stevens-Johnson: \u00c9tude R\u00e9trospective De 30 Cas. Ann Burns Fire Disasters. 2022, 35:116-124.","journal-title":"Ann Burns Fire Disasters"},{"key":"ref3","article-title":"Les Leviers de performance de L'assurance maladie obligatoire au maroc","volume":"21","author":"Sninate I","year":"2017","unstructured":"Sninate I, Bennana A. Les Leviers de performance de L'assurance maladie obligatoire au maroc. J Maroc des Sci Med. 2017, 21:1-8.","journal-title":"J Maroc des Sci Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2005.11.012","article-title":"Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding","volume":"6","author":"French LE","year":"2006","unstructured":"French LE, Trent JT, Kerdel FA. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Int Immunopharmacol. 2006, 6:543-549. 10.1016\/j.intimp.2005.11.012","journal-title":"Int Immunopharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.913682","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"10","author":"Mockenhaupt M","year":"2014","unstructured":"Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Rev Clin Immunol. 2014, 10:803-813. 10.1586\/1744666X.2014.913682","journal-title":"Expert Rev Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(02)00003-8","article-title":"Epidemiology of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis","volume":"20","author":"Rzany B","year":"2002","unstructured":"Rzany B, Mockenhaupt M. Epidemiology of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Dermat Clin. 2002, 20:219-228. 10.1016\/S0733-8635(02)00003-8","journal-title":"Dermat Clin"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer D","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, et al.. U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol. 2016, 174:1194-1227. 10.1111\/bjd.14530","journal-title":"Br J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr T","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010, 5:39. 10.1186\/1750-1172-5-39","journal-title":"Orphanet J Rare Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.11604\/pamj-cm.2020.4.73.22421","article-title":"La ne\u0301crolyse e\u0301pidermique toxique secondaire a\u0300 la prise d \u0301allopurinol: a\u0300 propos d \u0301un cas","volume":"4","author":"Nanzir ES","year":"2020","unstructured":"Nanzir ES, Touzani S, Houari N. La ne\u0301crolyse e\u0301pidermique toxique secondaire a\u0300 la prise d \u0301allopurinol: a\u0300 propos d \u0301un cas. PAMJ Clin Med. 2020, 4:10.11604\/pamj-cm.2020.4.73.22421","journal-title":"PAMJ Clin Med"},{"key":"ref10","unstructured":"Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). (2024). https.\/\/www.msdmanuals.com\/professional\/dermatologic-disorders\/hypersensitivity-and-reactive-skin-disorders\/stevens-j...."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin S","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000, 115:149-153. 10.1046\/j.1523-1747.2000.00061.x","journal-title":"J Invest Dermatol"},{"key":"ref12","article-title":"Review of intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"2","author":"Momin SB","year":"2009","unstructured":"Momin SB. Review of intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis. J Clin Aesthet Dermatol. 2009, 2:51-58.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jbcr\/irac046","article-title":"Immunomodulatory treatment of Lyell's syndrome: a simultaneous plasmapheresis and intravenous immunoglobulins therapy","volume":"43","author":"Stru\u017cyna J","year":"2022","unstructured":"Stru\u017cyna J, Surowiecka A, Korzeniowski T, et al.. Immunomodulatory treatment of Lyell's syndrome: a simultaneous plasmapheresis and intravenous immunoglobulins therapy. J Burn Care Res. 2022, 43:1394-1398. 10.1093\/jbcr\/irac046","journal-title":"J Burn Care Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck J","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, Sassolas B, Roujeau JC, Mockenhaupt M. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol. 2008, 58:33-40. 10.1016\/j.jaad.2007.08.039","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.1.33","article-title":"Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression","volume":"139","author":"Bachot N","year":"2003","unstructured":"Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol. 2003, 139:33-36. 10.1001\/archderm.139.1.33","journal-title":"Arch Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.03.044","article-title":"The risk of malignancy among biologic-na\u00efve pediatric psoriasis patients: a retrospective cohort study in a US claims database","volume":"77","author":"Gu Y","year":"2017","unstructured":"Gu Y, Nordstrom BL. The risk of malignancy among biologic-na\u00efve pediatric psoriasis patients: a retrospective cohort study in a US claims database. J Am Acad Dermatol. 2017, 77:293.e1-301.e1. 10.1016\/j.jaad.2017.03.044","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/224985-lamotrigine-induced-toxic-epidermal-necrolysis-lyells-syndrome-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:54:38Z","timestamp":1748404478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/224985-lamotrigine-induced-toxic-epidermal-necrolysis-lyells-syndrome-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.84929","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,27]]}}}